Redera, Ledelyn A.

HRN: 21-56-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2022
CEFUROXIME 500MG (TAB)
06/21/2022
06/27/2022
ORAL
500mg/tab
BID
S/P 1° CS
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominalReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: